Related Experiment Video
Updated: Apr 21, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Impact of peripheral arterial disease and cerebrovascular disease on outcomes in patients undergoing PCI
Pavan Gadhe1, Raman Sharma1, Serdar Farhan2
1Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
Insights
Patients with peripheral arterial disease (PAD) or cerebrovascular disease (CeVD) face higher risks of major adverse cardiovascular and cerebrovascular events (MACCE) after percutaneous coronary intervention (PCI). Subgroup analysis revealed prior interventions or stroke with hemiparesis significantly elevate these risks.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Patients with peripheral arterial disease (PAD) and cerebrovascular disease (CeVD) often experience poorer outcomes following percutaneous coronary intervention (PCI) for coronary artery disease (CAD).
- Understanding the impact of these comorbidities and their specific presentations is crucial for risk stratification and management.
Purpose of the Study:
- To investigate the influence of PAD and CeVD, including their subtypes, on clinical outcomes in patients undergoing PCI.
- To identify specific patient subgroups at higher risk for adverse events post-PCI.
Main Methods:
- A retrospective cohort study analyzed 21,978 patients undergoing PCI between 2012 and 2022.
- Patients were stratified based on the presence and subtypes of PAD and CeVD.
- Outcomes including Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) and bleeding were assessed at 1-year.
Main Results:
- Patients with PAD, CeVD, or both (polyvascular) had a significantly higher 1-year MACCE risk compared to the control group (CAD only).
- The highest MACCE risk was observed in patients with PAD and prior intervention, and CeVD with cerebrovascular accident (CVA) and hemiparesis.
- Bleeding events were more frequent in polyvascular and PAD patients, particularly those with prior intervention.
Conclusions:
- PAD, CeVD, and polyvascular disease are associated with increased MACCE risk in patients undergoing PCI.
- Prior interventions and CVA with hemiparesis are key drivers of this elevated MACCE risk.
- PAD and polyvascular disease, especially with prior intervention, are linked to a higher risk of bleeding events.
Abstract:
Background: Patients with peripheral arterial disease (PAD) or cerebrovascular disease (CeVD) are known to have worse outcomes when undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Methods: We conducted a retrospective cohort study to investigate the impact of PAD and CeVD, and their various presentation subtypes on the clinical outcomes in patients undergoing PCI. 21,978 patients undergoing PCI at the Mount Sinai Hospital between 2012 and 2022 were stratified by the presence of PAD and/or CeVD and their most common presentation subtypes. Results: Among the cohorts 1,613 (7.3%) patients had PAD, 1,874 (8.5%) had CeVD and 453 (2.1%) had both (polyvascular group) while the CAD only (control group) 18,038 (82.1%) had neither. 1-year risk of MACCE was significantly higher for patients with PAD, CeVD or both where patients presenting with PAD and prior intervention and CeVD with past cerebrovascular accident (CVA) with hemiparesis had the highest risk among the various subgroups. Patients with a history of CVA with/without hemiparesis had a higher risk of stroke post PCI. Bleeding events were more frequent in polyvascular and PAD patients, on subgroup analysis only the PAD with prior intervention subgroup was statistically significant. Conclusion: PAD, CeVD and polyvascular disease demonstrate a higher risk of MACCE in patients undergoing PCI. This increased risk of MACCE appears to be driven by those with prior intervention or CVA with hemiparesis. An increased risk of bleeding is seen in patients with PAD, polyvascular disease and PAD with prior intervention when stratified by subgroup.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests